Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication

Bibliography

• The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 2007;25:1105-87
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 2004;27:S65-7
   PubMedGoogle Scholar
• Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007;167:141-7
   PubMed Web of Science ®Google Scholar
• Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75
   PubMed Web of Science ®Google Scholar
• Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007;55:1056-65
   PubMed Web of Science ®Google Scholar
• Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens 2004;26:731-8
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-9
   PubMed Web of Science ®Google Scholar
• Stangier J, Su CA, Roth W. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J Int Med Res 2000;28:149-67
   PubMed Web of Science ®Google Scholar
• Neldam S, Edwards C. Telmisartan/Hydrochlorothiazide Investigators. Efficacy and safety of a fixed-dose combination of telmisartan 80 mg and hydrochlorothiazide 25 mg in patients with uncontrolled hypertension. J Clin Hypertens (Greenwich) 2008;10:612-8
   PubMed Web of Science ®Google Scholar
• Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005;111:697-716
   PubMed Web of Science ®Google Scholar
• White WB, Punzi HA, Murwin D, et al. Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension. J Clin Hypertens (Greenwich) 2006;8:626-33
   PubMedGoogle Scholar
• Ofili EO. Dispelling the myth of “aggressive” antihypertensive therapy. J Clin Hypertens (Greenwich) 2006;8(1 Suppl 1):4-11
   PubMedGoogle Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Gattobigio R, Sardone M, Rebolidi G. White-coat hypertension in adults. Blood Press Monit 2005;10:301-5
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:e510-26
   PubMed Web of Science ®Google Scholar
• Bangalore S, Shahane A, Parkar S, Messerli FH. Compliance and fixed-dose combination therapy. Curr Hypertens Rep 2007;9:184-9
   PubMed Web of Science ®Google Scholar
• Waeber B, Burnier M, Brunner HR. Compliance with antihypertensive therapy. Clin Exp Hypertens 1999;21:973-85
   PubMed Web of Science ®Google Scholar
• Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005;39:1198-203
   PubMed Web of Science ®Google Scholar
• Mazzolai L, Burnier M. Comparative safety and tolerability of angiotensin II receptor antagonists. Drug Saf 1999;21:23-33
   PubMed Web of Science ®Google Scholar
• Vinker S, Alkalay A, Hoffman RD, et al. Long-term adherence to antihypertensive therapy: a survey in four primary care clinics. Expert Opin Pharmacother 2008;9:1271-7
   PubMed Web of Science ®Google Scholar
• Lachaine J, Petrella RJ, Merikle E, Ali F. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data. Can J Cardiol 2008;24:269-73
   PubMed Web of Science ®Google Scholar
• Yusuf S, Teo KK, Pogue J, et al, ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-59
   PubMed Web of Science ®Google Scholar